Table 1 Demographic and clinical characteristics of gastroesophageal reflux disease patients (SES) n (%) or mean (min/max)

Mean age, years (min/max)

54.4 (28/81)

Females

17 (36.2%)

Mean BMI, kg / m² (min/max)

26.7 (21.5/35.2)

Mean Duration of PPI use, years (min/max)

5 (1/21)

Omeprazol

6 (12.8%)

1 x 10 mg

1 (2.1%)

1 x 20 mg

4 (8.5%)

2 x 20 mg

1 (2.1%)

Esomeprazol

9 (19.1%)

1 x 20 mg

4 (8.5%)

1 x 40 mg

2 (4.3%)

2 x 40 mg

2 (4.3%)

1 x 80 mg

1 (2.1%)

Pantoprazol

31 (66.0%)

1 x 20 mg

20 (42.6%)

1 x 40 mg

10 (21.3%)

2 x 40 mg

1 (2.1%)

Missing detailed information on PPI use

1 (2.1%)